Search Results 661-670 of 16956 for Radioisotope
10 Mayo Clinic research advances in 2024, spanning stem cell therapy in space to growing mini-organs. Mayo Clinic Staff. December 30, 2024.
A Phase 1 Dose Escalation and Expansion Study of TGR-1202 + Ruxolitinib in Subjects with Primary Myelofibrosis (PMF), Post-Polycythemia Vera MF (PPV-MF), ...
Mayo Clinic Oncology — Medical oncologists at Mayo Clinic offer innovative treatments for cancers of the organs, bones, muscles and connective tissues.
The purpose of this study is to study the length of the QTc interval in patients receiving the standard of care dose of intravenous droperidol for headache ...
This study aims to evaluate the safety of preoperative radiosurgery in the treatment of patients with biopsy-proven high grade glioma prior to conventional ...
Immunotherapy with monoclonal antibodies, such as atezolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor ...
About this study. The purpose of this study is to investigate if Hybrid Argon Plasma Coagulation (HAPC) is non-inferior to Radiofrequency Ablation (RFA) in ...
Comparison of the Diagnostic Accuracy of Fujifilm Endoscopic Hypoxia Imaging (FEHI) to Indocyanine Green Fluorescein Imaging in Assessing Intraoperative Tissue ...
Hematology — Learn about innovative diagnosis and treatment options for blood diseases, including cancers, at Mayo Clinic.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Hurry to 3X your gift’s impact on cancer research and care!